MARK ZOLMAN, M.D.
Physical Medicine & Rehabilitation Physician in FORT WAYNE, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MARK ZOLMAN, M.D. reported a CMS MIPS final score of 94.0056/100 — above the 83.1 national average — and filed 647 Medicare Part D claims in 2023.
- 94.0056/100
- MIPS score · +11 vs avg
- 647
- Part D claims, 2023
- 97%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MARK ZOLMAN, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
94 Top 25% higher than 75% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
MARK ZOLMAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MARK ZOLMAN, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Indiana
How Physical Medicine & Rehabilitation Physician compares to other specialties among Indiana providers
Physical Medicine & Rehabilitation Physician share within Indiana
Physical Medicine & Rehabilitation Physician is one of the more visible NUCC categories in Indiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MARK ZOLMAN, M.D.'s 2023 MIPS final score plotted against the Physical Medicine & Rehabilitation Physician national average
- MIPS Final Score
- 94.0056/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Physical Medicine & Rehabilitation Physician) — 94.0056/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Physical Medicine & Rehabilitation Physician US NPIs
94.0056/100 MIPS final score — 10.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Physical Medicine & Rehabilitation Physician. Quality dim: 88.0112.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARK ZOLMAN, M.D. appears in the CMS NPPES registry as a Physical Medicine & Rehabilitation Physician provider holding M.D. credentials at 7201 ENGLE RD, FORT WAYNE, IN, 46804, with a listed phone of (260) 432-1800. NPI 1467455436 was issued on 05/24/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ZOLMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 647 prescription claims written by this provider, covering 145 Medicare beneficiaries and totaling roughly $26K in drug spend, split 3% brand-name and 97% generic by claim count, with an opioid prescribing rate of 53.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.0056/100 for the 2023 performance year (Quality 88.0112), compared with the national average of 83.1.
Physical Medicine & Rehabilitation Physician is a mid-sized specialty nationwide, with 15,306 enrolled providers across 54 states and an average of 781 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1467455436 |
|---|---|
| Specialty | Physical Medicine & Rehabilitation Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/24/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARK ZOLMAN, M.D.'s current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK ZOLMAN, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$15
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
3% brand-name claims vs 97% generic, on 647 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 822
- Total Day Supply
- 23,222
- Brand vs Generic
- 3% brand / 97% generic
- Brand Drug Cost
- $6K
- Generic Drug Cost
- $20K
- Opioid Claims
- 346 (53.5% rate)
- Antibiotic Claims
- 13
Patient Demographics
- Average Patient Age
- 72.2 years
- Avg HCC Risk Score
- 1.29
- Gender Split
- 70% female / 30% male
- Age Distribution
- <65: 33, 65-74: 47, 75-84: 52, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MARK ZOLMAN, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
163 claims
- Gabapentin
Gabapentin
66 claims
- Tramadol Hcl 65
Tramadol Hcl
65 claims
- Oxycodone-Acetamin… 35
Oxycodone-Acetaminophen
35 claims
- Pregabalin 34
Pregabalin
34 claims
- Baclofen 27
Baclofen
27 claims
- Fentanyl 27
Fentanyl
27 claims
- Meloxicam 24
Meloxicam
24 claims
| Drug | Claims |
|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 163 |
| Gabapentin | 66 |
| Tramadol Hcl | 65 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 35 |
| Pregabalin | 34 |
| Baclofen | 27 |
| Fentanyl | 27 |
| Meloxicam | 24 |
| Cyclobenzaprine Hcl | 21 |
| Morphine Sulfate Er Morphine Sulfate | 17 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Physical Medicine & Rehabilitation Physician Overview
How MARK ZOLMAN, M.D. fits within the Physical Medicine & Rehabilitation Physician landscape nationally.
MARK ZOLMAN, M.D.'s 647 claims are below the specialty average of 781.
Nearby Physical Medicine & Rehabilitation Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as ZOLMAN.
Compare Physical Medicine & Rehabilitation Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Indiana
Frequently Asked Questions
What is MARK ZOLMAN, M.D.'s specialty? ▼
How much does MARK ZOLMAN, M.D. prescribe under Medicare Part D? ▼
What is MARK ZOLMAN, M.D.'s Medicare quality score? ▼
Where is MARK ZOLMAN, M.D. located? ▼
What is MARK ZOLMAN, M.D.'s NPI number? ▼
Does MARK ZOLMAN, M.D. prescribe more brand-name or generic drugs? ▼
Does MARK ZOLMAN, M.D. prescribe opioids? ▼
How many Physical Medicine & Rehabilitation Physician providers are there in the US? ▼
What drugs does MARK ZOLMAN, M.D. prescribe most often? ▼
Does MARK ZOLMAN, M.D. accept Medicare? ▼
How can I verify MARK ZOLMAN, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology